New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer!
For Fatal Rhabdomyosarcoma, New Atr Inhibitors May Hold Therapeutic Promise
Memorial Sloan Kettering Cancer Centre, USA
Airway Announces First Patient To Receive Dose In Bpd Trial
The New Generation Of Breast Cancer SERD Drug, Elastoxan, Shows Promise!
New Research: Cracking The Targeted Drug Resistance Puzzle And Eliminating Cancer Cells Before They Evolve!
